You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 273 No. 21, June 7, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Rheumatology

G. S. Alarcon and K. V. Straaton
University of Alabama at Birmingham, USA.

In some populations, the presence and the dose of the "rheumatoid" epitope have been associated with severe rheumatoid arthritis. Newer treatments include oral antibiotics, oral type II collagen, and a number of biological products. Identification of a mutation in the type II procollagen genes is evidence that some clinical osteoarthritis is genetically related.





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.